Evidence map›Paper›PMID 30252044›Full record

ArticleBrain : a journal of neurology2018

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

Ming Zhang, Raffaele Ferrari, Maria Carmela Tartaglia, Julia Keith, Ezequiel I Surace, Uri Wolf, Christine Sato, Mark Grinberg, Yan Liang, Zhengrui Xi and 71 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06529744 (Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06529744 recruitingnot on this mapstarted 2023, after this paper: background citation

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

Typeobservational_patient_registrySponsorUniversity Health Network, TorontoRan2023 to 2027Enrolled500ConditionsDementia, Alzheimer Disease, Dementia With Lewy Bodies, Vascular Dementia
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontotemporal lobar degeneration.Nature reviews. Disease primers · 2023
    Review
  9. Review
  10. TheInternational journal of molecular sciences · 2022
    Article
  11. Trans-Ethnic Fine-Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  12. Article
  13. Review
  14. Early-Onset Alzheimer's Disease: What Is Missing in Research?Current neurology and neuroscience reports · 2021
    Review
  15. Article
  16. Article
  17. Neurology · 2020
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

81 authors at 20 institutions in 13 countries.

Ming ZhangShanghai First Rehabilitation Hospital, School of Medicine, Tongji University, Shanghai, China.
Raffaele FerrariDepartment of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Maria Carmela TartagliaTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Julia KeithSunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Ezequiel I SuraceLaboratorio de Biología Molecular, Departamento de Neuropatología, Instituto de Investigaciones Neurológicas Dr. Raúl Carrea (FLENI), Buenos Aires, Argentina.
Uri WolfBaycrest Health Science, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Christine SatoTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Mark GrinbergTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Yan LiangTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Zhengrui XiTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Kyle DupontTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Philip McGoldrickTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Anna WeichertTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Paul M McKeeverTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Raphael SchneiderTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Michael D McCorkindaleDepartment of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Claudia ManzoniSchool of Pharmacy, University of Reading, Whiteknights, Reading, UK.
Rosa RademakersDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Joseph E ParisiDepartment of Laboratory Medicine and Pathology and Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Bruce L MillerDepartment of Neurology, University of California San Francisco Memory and Aging Center, San Francisco, CA, USA.
William W SeeleyDepartment of Neurology and Department of Pathology, University of California San Francisco Memory and Aging Center, San Francisco, CA, USA.
John C van SwietenDepartment of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Jeroen van RooijDepartment of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Yolande PijnenburgAlzheimer Center, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Julie van der ZeeNeurodegenerative Brain Diseases, Center of Molecular Neurology, VIB, Antwerp, Belgium.
Christine Van BroeckhovenNeurodegenerative Brain Diseases, Center of Molecular Neurology, VIB, Antwerp, Belgium.
Isabelle Le BerSorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Institut du Cerveau et la Moelle épinière (ICM), Paris, France.
Vivianna Van DeerlinCenter for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
EunRan SuhCenter for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Jonathan D RohrerDementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
Simon MeadMRC Prion Unit at UCL, Institute of Prion Diseases, London, UK.
Caroline GraffDivision of Neurogeriatrics, Alzheimer Research Center, Karolinska Institutet, Solna, Sweden.
Linn ÖijerstedtDivision of Neurogeriatrics, Alzheimer Research Center, Karolinska Institutet, Solna, Sweden.
Stuart Pickering-BrownDivision of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, University of Manchester, UK.
Sara RollinsonDivision of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, University of Manchester, UK.
Giacomina RossiDivision of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Fabrizio TagliaviniScientific Directorate, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
William S BrooksNeuroscience Research Australia and Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
Carol Dobson-StoneBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Glenda M HallidayBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
John R HodgesBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Olivier PiguetAustralian Research Council Centre of Excellence in Cognition and its Disorders, Sydney, Australia.
Giuliano BinettiMAC Memory Center, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Luisa BenussiMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Roberta GhidoniMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Benedetta NacmiasDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Sandro SorbiDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Amalia C BruniRegional Neurogenetic Centre, Lamezia Terme, Azienda Sanitaria Provinciale Catanzaro, Italy.
Daniela GalimbertiNeurodegenerative Disease Unit, University of Milan, Fondazione Ca' Granda, IRCCS Ospedale Policlinico, Milan, Italy.
Elio ScarpiniNeurodegenerative Disease Unit, University of Milan, Fondazione Ca' Granda, IRCCS Ospedale Policlinico, Milan, Italy.
Innocenzo RaineroDepartment of Neuroscience "Rita Levi Montalcini", University of Torino, Torino, Italy.
Elisa RubinoDepartment of Neuroscience "Rita Levi Montalcini", University of Torino, Torino, Italy.
Jordi ClarimonIIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.
Alberto LleóIIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.
Agustin RuizResearch Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades-Universitat Internacional de Catalunya, Barcelona, Spain.
Isabel HernándezResearch Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades-Universitat Internacional de Catalunya, Barcelona, Spain.
Pau PastorMemory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, Barcelona, Spain.
Monica Diez-FairenMemory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, Barcelona, Spain.
Barbara BorroniCentre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Florence PasquierNational Reference Center for Young Onset Dementia, Neurology Department, Centre Hospitalier Régional Universitaire de Lille, University Hospital, Inserm U1171, DistAlz, Lille, France.
Vincent DeramecourtNational Reference Center for Young Onset Dementia, Neurology Department, Centre Hospitalier Régional Universitaire de Lille, University Hospital, Inserm U1171, DistAlz, Lille, France.
Thibaud LebouvierNational Reference Center for Young Onset Dementia, Neurology Department, Centre Hospitalier Régional Universitaire de Lille, University Hospital, Inserm U1171, DistAlz, Lille, France.
Robert PerneczkyDepartment of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany.
Janine Diehl-SchmidDepartment of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany.
Jordan GrafmanCognitive Neurology and Alzheimer's Center, Department of Psychiatry, Feinberg School of Medicine Chicago, IL, USA.
Edward D HueyThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, USA.
Richard MayeuxThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, USA.
Michael A NallsLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Dena HernandezLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Andrew SingletonLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Parastoo MomeniRona Holdings, Silicon Valley, CA, USA.
Zhen ZengMerck & Co., Inc, Kenilworth, NJ, USA.
John HardyDepartment of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Janice RobertsonTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Lorne ZinmanDepartment of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada.
Ekaterina RogaevaTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
International FTD-Genomics Consortium (IFGC)
University of Toronto · CAOccupational Cancer Research Centre · CAUniversity College London · GBCentro San Giovanni di Dio Fatebenefratelli · ITNational Institute on Aging · USUniversity of Manchester · GBMayo Clinic in Arizona · USCentre Hospitalier Universitaire de Lille · FRFondazione IRCCS Istituto Neurologico Carlo Besta · ITMayo Clinic in Florida · USUniversity of California, San Francisco · USUniversity of Turin · ITAustralian Research Council · AUCanada Research Chairs · CAFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITFundació ACE · ESKarolinska Institutet · SEMayo Clinic · USMútua Terrassa · ESTechnical University of Munich · DE

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI SCHINDLER, SUZANNE ELIZABETH · 2005 to 2025
$49.5M
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
Project 3: Neuropathology of the multi-proteinopathy of c9FTD/ALS.P01NS084974 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2014 to 2024
$17.6M
Genetic Analysis Of Non- Alzheimer's disease DementiasZIAAG000951 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2020
$5.6M
Genetic Discovery and Pathobiology of Frontotemporal Lobar Degeneration and Related TDP-43 ProteinopathiesR35NS097261 · NINDS · MAYO CLINIC JACKSONVILLE · PI RADEMAKERS, ROSA · 2017 to 2019
$2.9M
Medical Research Council G0400074Medical Research Council G0502157Medical Research Council G0900652Medical Research Council G1100540Medical Research Council MC_U105597119Medical Research Council MC_UU_00005/12Medical Research Council MC_UU_00024/1Medical Research Council MR/M008525/1Medical Research Council MR/M023664/1NIA NIH HHS P01 AG017586NIA NIH HHS P01 AG019724NIA NIH HHS P01 AG026276NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG016574NINDS NIH HHS P01 NS084974NINDS NIH HHS R35 NS097261
6 · The paper itself

Abstract

The G4C2-repeat expansion in C9orf72 is the most common known cause of amyotrophic lateral sclerosis and frontotemporal dementia. The high phenotypic heterogeneity of C9orf72 patients includes a wide range in age of onset, modifiers of which are largely unknown. Age of onset could be influenced by environmental and genetic factors both of which may trigger DNA methylation changes at CpG sites. We tested the hypothesis that age of onset in C9orf72 patients is associated with some common single nucleotide polymorphisms causing a gain or loss of CpG sites and thus resulting in DNA methylation alterations. Combined analyses of epigenetic and genetic data have the advantage of detecting functional variants with reduced likelihood of false negative results due to excessive correction for multiple testing in genome-wide association studies. First, we estimated the association between age of onset in C9orf72 patients (n = 46) and the DNA methylation levels at all 7603 CpG sites available on the 450 k BeadChip that are mapped to common single nucleotide polymorphisms. This was followed by a genetic association study of the discovery (n = 144) and replication (n = 187) C9orf72 cohorts. We found that age of onset was reproducibly associated with polymorphisms within a 124.7 kb linkage disequilibrium block tagged by top-significant variation, rs9357140, and containing two overlapping genes (LOC101929163 and C6orf10). A meta-analysis of all 331 C9orf72 carriers revealed that every A-allele of rs9357140 reduced hazard by 30% (P = 0.0002); and the median age of onset in AA-carriers was 6 years later than GG-carriers. In addition, we investigated a cohort of C9orf72 negative patients (n = 2634) affected by frontotemporal dementia and/or amyotrophic lateral sclerosis; and also found that the AA-genotype of rs9357140 was associated with a later age of onset (adjusted P = 0.007 for recessive model). Phenotype analyses detected significant association only in the largest subgroup of patients with frontotemporal dementia (n = 2142, adjusted P = 0.01 for recessive model). Gene expression studies of frontal cortex tissues from 25 autopsy cases affected by amyotrophic lateral sclerosis revealed that the G-allele of rs9357140 is associated with increased brain expression of LOC101929163 (a non-coding RNA) and HLA-DRB1 (involved in initiating immune responses), while the A-allele is associated with their reduced expression. Our findings suggest that carriers of the rs9357140 GG-genotype (linked to an earlier age of onset) might be more prone to be in a pro-inflammatory state (e.g. by microglia) than AA-carriers. Further, investigating the functional links within the C6orf10/LOC101929163/HLA-DRB1 pathway will be critical to better define age-dependent pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.

Indexed as

AgedAge of OnsetAmyotrophic Lateral SclerosisC9orf72 ProteinCpG IslandsDNA MethylationFemaleFrontotemporal DementiaGene Expression RegulationGenotypeHeterozygoteHumansMaleMiddle AgedPolymorphism, Single NucleotideC9orf72 ProteinC9orf72 protein, human

Identifiers

PMID30252044
PMCPMC6158742
OpenAlexW2892538941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.